Retrospective study of cetuximab concurrent with postoperative radiation in poor risk patients with resected squamous cell carcinomas of the head and neck.
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2015
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 21 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.